United Therapeutics's annual revenues are over $500 million (see exact revenue data) and has 500-1,000 employees. It is classified as operating in the Professional & Commercial Equipment & Supplies Merchant Wholesalers industry.
United Therapeutics's Annual Report & Profile shows critical firmographic facts:
What is the company's size? (Annual sales and employees)
What industry is the company in?
United Therapeutics is a publicly traded company on NMS using the ticker symbol UTHR.
Detailed information on company financials and operating reports can be found here:
United Therapeutics Annual Revenue and Growth Rate
Note: United Therapeutics's revenues are gauged from an analysis of company filings.
Trademark applications show the products and services that United Therapeutics is developing and marketing.
United Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
TYVASO DPI Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis
TYVASO DPI TREPROSTINIL INHALATION POWDER Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis
IMPLANTABLE SYSTEM FOR REMODULIN TREPROSTINIL INJECTION Pharmaceutical preparation used in the treatment of cardiovascular, cardiopulmonary, cardiovascular, pulmonary, and vascular diseases
Determine whether United Therapeutics grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof United Therapeutics is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of United Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as United Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to United Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: United Therapeutics's Fastest Growing Competitors
These companies are in the same general field as United Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.